Concepedia

Amal A. Fyiad

AA

Statistics

Publications

3

Citations

99

H-Index

3

Active since

2014

Affiliations

Helwan University(Current)

National Research Centre

Children Cancer Hospital

Cairo University

Texas A&M University – Kingsville

Amal A. Fyiad is an author at Helwan University specializing in checkpoint kinase 2 signaling, drug discovery, and cancer pharmacology.

ORCID

Publications per year

2014–2017

3

Publications

3

Part I: Design, synthesis and biological evaluation of novel pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors with studying their activities alone and in combination with genotoxic drugs

Ahmed S. Abdelsamie, Samia A. Shouman, Yasmin M. Attia et al. · European Journal of Medicinal Chemistry · 2017 · 44 citations · Full text

, , +14

Part II: New candidates of pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors

Shadia A. Galal, Sarah H. M. Khairat, Hamed I. Ali et al. · European Journal of Medicinal Chemistry · 2017 · 29 citations · Full text

, , +17

Phytochemical Analysis and Antimicrobial Activity of Mangrove Leaves (Avicenna marina and Rhizophora stylosa) Against Some Pathogens

Foukia E. Mouafi, Shadia M. Abdel-Aziz, Awatif A. Bashir et al. · 2014 · 26 citations

, , +14

1–3 of 3